ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The PROTAC induced the degradation of BCR-ABL1 and c-ABL1 in a human CML cell line and murine BCR-ABL1 transformed cells, and inhibited cell proliferation with an IC50 of approximately 1 μM.